Literature DB >> 21454673

Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.

Christoph Garbers1, Nathalie Jänner, Athena Chalaris, Marcia L Moss, Doreen M Floss, Dörte Meyer, Friedrich Koch-Nolte, Stefan Rose-John, Jürgen Scheller.   

Abstract

Hypomorphic ADAM17(ex/ex) mice showed defects in mucosal regeneration due to inefficient enhanced GFR shedding. ADAM17 is the main sheddase of interleukin-6 receptor (IL-6R) to induce IL-6 trans-signaling. However, serum levels of soluble murine IL-6R were not reduced in ADAM17(ex/ex) mice, and murine ADAM17 was not the major sheddase of murine IL-6R. Shedding of murine IL-6R by murine ADAM17 was rescued in chimeric murine IL-6R proteins containing any extracellular domain but not the transmembrane and intracellular domain of human IL-6R. Apoptosis is a physiological stimulus of ADAM17-mediated shedding of human IL-6R. Even though apoptosis induced IL-6R shedding in mice, the responsible protease was identified as ADAM10. ADAM10 also was identified as protease responsible for ionomycin-induced shedding of murine and human IL-6R. However, in ADAM10-deficient murine embryonic fibroblasts, compensatory shedding of human IL-6R was mediated by ADAM17, but loss of ADAM10-mediated shedding of murine IL-6R was compensated by an as-yet-unidentified protease. Finally, we identified physiological purinergic P2X7 receptor stimulation as a novel inducer of murine and human IL-6R shedding solely mediated by ADAM10. In conclusion, we describe an unexpected species specificity of ADAM10 and ADAM17 and identified ADAM10 as novel inducible sheddase of IL-6R in mice and humans, which might have consequences for the interpretation of phenotypes from ADAM17- and ADAM10-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454673      PMCID: PMC3083187          DOI: 10.1074/jbc.M111.229393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding.

Authors:  Miki Hamaoka; Ichino Chinen; Takuya Murata; Seiji Takashima; Ryo Iwamoto; Eisuke Mekada
Journal:  J Biochem       Date:  2010-03-23       Impact factor: 3.387

Review 2.  ADAMs: key components in EGFR signalling and development.

Authors:  Carl P Blobel
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

3.  ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.

Authors:  Gisela Weskamp; Jill W Ford; Jamie Sturgill; Steve Martin; Andrew J P Docherty; Steven Swendeman; Neil Broadway; Dieter Hartmann; Paul Saftig; Shelby Umland; Atsuko Sehara-Fujisawa; Roy A Black; Andreas Ludwig; J David Becherer; Daniel H Conrad; Carl P Blobel
Journal:  Nat Immunol       Date:  2006-10-29       Impact factor: 25.606

4.  ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding.

Authors:  Ying Li; Jennifer Brazzell; Amy Herrera; Bruce Walcheck
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

5.  Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.

Authors:  S M Dethlefsen; G Raab; M A Moses; R M Adam; M Klagsbrun; M R Freeman
Journal:  J Cell Biochem       Date:  1998-05-01       Impact factor: 4.429

6.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Authors:  Christian Hundhausen; Dominika Misztela; Theo A Berkhout; Neil Broadway; Paul Saftig; Karina Reiss; Dieter Hartmann; Falk Fahrenholz; Rolf Postina; Vance Matthews; Karl-Josef Kallen; Stefan Rose-John; Andreas Ludwig
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

7.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

8.  Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.

Authors:  Felix Scholz; Alexander Schulte; Frederic Adamski; Christian Hundhausen; Jens Mittag; Agatha Schwarz; Marie-Luise Kruse; Ehrhardt Proksch; Andreas Ludwig
Journal:  J Invest Dermatol       Date:  2007-03-15       Impact factor: 8.551

9.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

10.  ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.

Authors:  Sylvain M Le Gall; Pierre Bobé; Karina Reiss; Keisuke Horiuchi; Xiao-Da Niu; Daniel Lundell; David R Gibb; Daniel Conrad; Paul Saftig; Carl P Blobel
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

View more
  76 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.

Authors:  Thorben M Hummel; Theresa Ackfeld; Marco Schönberg; Gregor Ciupka; Falk Schulz; Anne Oberdoerster; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

Review 3.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

4.  A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Authors:  Katja Möller-Hackbarth; Christin Dewitz; Olga Schweigert; Ahmad Trad; Christoph Garbers; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

5.  Lost in Trans-IL-6 Signaling: Alveolar Type II Cell Death in Emphysema.

Authors:  Irina Petrache; Karina Serban
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

6.  A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.

Authors:  Patrick C G Haddick; Jessica L Larson; Nisha Rathore; Tushar R Bhangale; Qui T Phung; Karpagam Srinivasan; David V Hansen; Jennie R Lill; Margaret A Pericak-Vance; Jonathan Haines; Lindsay A Farrer; John S Kauwe; Gerard D Schellenberg; Carlos Cruchaga; Alison M Goate; Timothy W Behrens; Ryan J Watts; Robert R Graham; Joshua S Kaminker; Marcel van der Brug
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis.

Authors:  Narelle E McGregor; Melissa Murat; Jeevithan Elango; Ingrid J Poulton; Emma C Walker; Blessing Crimeen-Irwin; Patricia W M Ho; Jonathan H Gooi; T John Martin; Natalie A Sims
Journal:  J Biol Chem       Date:  2019-03-28       Impact factor: 5.157

8.  RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.

Authors:  Florian Mittelberger; Cindy Meyer; Georg H Waetzig; Martin Zacharias; Erica Valentini; Dmitri I Svergun; Katharina Berg; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

9.  Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).

Authors:  Christoph Garbers; Fabian Kuck; Samadhi Aparicio-Siegmund; Kirstin Konzak; Mareike Kessenbrock; Annika Sommerfeld; Dieter Häussinger; Philipp A Lang; Dirk Brenner; Tak W Mak; Stefan Rose-John; Frank Essmann; Klaus Schulze-Osthoff; Roland P Piekorz; Jürgen Scheller
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

10.  miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.

Authors:  Eun-Ah Ye; Jena J Steinle
Journal:  Vision Res       Date:  2017-04-26       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.